5 years 1 month ago
Hand OA responds to 10mg/d Pred over 6wks. As expected symptoms return on cessation Anecdotally, there are people who do well on pragmatic, long term low dose eg 5mg or less/d #ACR19 @rheumnow Abst1760 https://t.co/FtE9vHb655
Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni
Dr. Husni highlights abstract #1769 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Use of TNF Inhibitors: Dr. Olga Petryna
Dr. Olga Petryna discusses abstract #377 presented at the 2019 ACR/ARP annual meeting in Atlanta.
5 years 1 month ago
The C-AxSpand study, Certolizumab-treated nr-axSpA pts with shorter symptom duration (< 5 vs ≥ 5 years) showed greater improvements across signs and symptoms of disease and in quality of life. Kay J et al #ACR19 @RheumNow
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.
Study of ANA+ people without lupus or CTD shows that fatigue does not increase odds of having lupus or CTD.…
